Quinolinic acid

From NuGOwiki

(Redirected from HMDB00232)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

Quinolinic acid
2D structure for Quinolinic acid
Chemical Name 2,3-Pyridinedicarboxylic acid
Chemical Formula C7H5NO4
CAS Number 89-00-9
Chemical Information HMDB00232
Biochemical Taxonomy

  • Dicarboxylic Acids

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways

  • Nicotinate and Nicotinamide Metabolism

Biofluid Location

  • Blood
  • Cerebrospinal Fluid (CSF)
  • Urine

Tissue Location

  • Central Nervous System
  • Neurons
  • Spleen
  • Brain

Normal Biofluid Concentrations

  • Blood: 0.47 +/- 0.047 umol/L
  • Cerebrospinal Fluid (CSF): 0.018 (0.012-0.024) uM
  • Cerebrospinal Fluid (CSF): 0.018 +/- 0.006 uM
  • Cerebrospinal Fluid (CSF): 0.02 +/- 0.002 uM
  • Cerebrospinal Fluid (CSF): 0.022 +/- 0.0021 uM
  • Cerebrospinal Fluid (CSF): 0.023 +/- 0.002 uM
  • Cerebrospinal Fluid (CSF): 0.07 (0.05-0.10) uM
  • Cerebrospinal Fluid (CSF): 0.07 (0.05-0.10) uM
  • Urine: 10.5 umol/mmol creatinine
  • Urine: 13.2 umol/mmol creatinine
  • Urine: 2.5 +/- 1.1 umol/mmol creatinine
  • Urine: 44.8 umol/mmol creatinine
  • Urine: 44.8 umol/mmol creatinine
  • Urine: 7.3 umol/mmol creatinine
  • Urine: 7.7 umol/mmol creatinine

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Anemia
  • Brain oedema or injury
  • CNS Infections
  • CNS Tumors
  • Cerebral malaria
  • Convulsions
  • HIV
  • Hepatic coma (fatal)
  • Hydrocephalus
  • Intraventricular Hemorrhage
  • Severe Malaria
  • TB meningitis
  • Uncomplicated malaria

Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations

  • Cerebrospinal Fluid (CSF) (Anemia): 0.10 (0-2.37) uM
  • Cerebrospinal Fluid (CSF) (Brain oedema or injury): 0.29 (0.17-0.41) uM
  • Cerebrospinal Fluid (CSF) (CNS Infections): 1.08 +/- 0.54 uM
  • Cerebrospinal Fluid (CSF) (CNS Tumors): 0.28 +/- 0.082 uM
  • Cerebrospinal Fluid (CSF) (Cerebral malaria): 0.09 (0.07-0.11) uM
  • Cerebrospinal Fluid (CSF) (Convulsions): 0.03 (0.01-0.13) uM
  • Cerebrospinal Fluid (CSF) (HIV): 3.78 +/- 0.88 uM
  • Cerebrospinal Fluid (CSF) (Hepatic coma (fatal)): 0.00015 (0.00011-0.00019) uM
  • Cerebrospinal Fluid (CSF) (Hydrocephalus): 0.031 +/- 0.005 uM
  • Cerebrospinal Fluid (CSF) (Intraventricular Hemorrhage): 0.2 +/- 0.113 uM
  • Cerebrospinal Fluid (CSF) (Severe Malaria): 0.8 (0.7-1.0) uM
  • Cerebrospinal Fluid (CSF) (TB meningitis): 6.10 (0.37-100.9) uM
  • Cerebrospinal Fluid (CSF) (Uncomplicated malaria): 0.08 (0.04-0.16) uM

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS. Quinolinic acid (QUIN) is a product of tryptophan metabolism that can act as an endogenous brain excitotoxin when released by activated macrophages. (Valle et. al, Brain 127:1047 (2004))

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • Anemia
  • Brain oedema or injury
  • CNS Infections
  • CNS Tumors
  • Cerebral malaria
  • Convulsions
  • HIV
  • Hepatic coma (fatal)
  • Hydrocephalus
  • Intraventricular Hemorrhage
  • Severe Malaria
  • TB meningitis
  • Uncomplicated malaria

Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines